Status: current, Defined. Date: 30-Nov 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3849621000168118 | Soflax (Ascent Pharma) (docusate sodium 50 mg + senna leaf powder 5 mg + sennoside B 8 mg) tablet, 100 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3849631000168115 | Soflax (Ascent Pharma) tablet, 100 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Soflax (Ascent Pharma) tablet, 100 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Soflax (Ascent Pharma) tablet, 100 | Is a | sennoside B 8 mg + senna leaf powder 5 mg + docusate sodium 50 mg tablet, 100 | true | Inferred relationship | Some | ||
| Soflax (Ascent Pharma) tablet, 100 | has TPUU | Soflax (Ascent Pharma) tablet | true | Inferred relationship | Some | 1 | |
| Soflax (Ascent Pharma) tablet, 100 | has TP | Soflax (Ascent Pharma) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Soflax (Ascent Pharma) tablet, 100, bottle | Is a | True | Soflax (Ascent Pharma) tablet, 100 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR